Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 147 No. 4142 (2017)

Evaluation of existing and desired antimicrobial stewardship activities and strategies in Swiss hospitals

  • Michael Osthoff
  • Julia Bielicki
  • Andreas F. Widmer
  • for Swissnoso
Cite this as:
Swiss Med Wkly. 2017;147:w14512


Antimicrobial stewardship (AMS) is an important component in the fight against antimicrobial resistance. Currently, few hospitals have an ongoing institutional AMS programme. Swissnoso – the national centre for infection prevention – has launched a national Swiss AMS initiative supported by the office of public health. To guide AMS priorities and resources, current AMS activities in Switzerland were assessed. We distributed an internet-based questionnaire directed mainly to board-certified infectious diseases specialists and, if not available, senior internal medicine staff. Responses were received from 63/134 hospitals surveyed. More than 90% were in favour of national treatment guidelines currently in development under the umbrella of the Swiss society for infectious diseases. Many AMS activities – such as antimicrobial formulary restrictions and approval systems, review of antimicrobial prescriptions with point of care intervention, and direct feedback or therapeutic drug monitoring – are currently lacking in the majority of Swiss hospitals surveyed. Development of a modular formal AMS standard for Swiss hospitals may aid in advancing current AMS strategies and in introducing AMS programmes in Switzerland. In combination with the surveillance of antimicrobial use and resistance by ANRESIS, the national antimicrobial resistance surveillance system, this approach may reduce the use of antimicrobial agents and consequently the risk of emergence of multi-resistant pathogens.


  1. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. 2014. Available from:
  2. Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, et al. Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol. 2017;38(7):848–56. doi:.
  3. Lim C, Takahashi E, Hongsuwan M, Wuthiekanun V, Thamlikitkul V, Hinjoy S, et al. Epidemiology and burden of multidrug-resistant bacterial infection in a developing country. eLife. 2016;5:5. doi:.
  4. Evans HL, Lefrak SN, Lyman J, Smith RL, Chong TW, McElearney ST, et al. Cost of Gram-negative resistance. Crit Care Med. 2007;35(1):89–95. doi:.
  5. The World Bank. Drug-resistant infections: a threat to our economic future. 2017. Available from:
  6. Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(7):1748–54. doi:.
  7. Brink AJ, Messina AP, Feldman C, Richards GA, Becker PJ, Goff DA, et al.; Netcare Antimicrobial Stewardship Study Alliance. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis. 2016;16(9):1017–25. doi:.
  8. Boel J, Andreasen V, Jarløv JO, Østergaard C, Gjørup I, Bøggild N, et al. Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme. J Antimicrob Chemother. 2016;71(7):2047–51. doi:.
  9. Naylor NR, Zhu N, Hulscher M, Holmes A, Ahmad R, Robotham JV. Is antimicrobial stewardship cost-effective? A narrative review of the evidence. Clin Microbiol Infect. 2017;S1198-743X(17)30330-0. [Epub ahead of print.]
  10. Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Döbele S, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990–1001. doi:.
  11. Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, et al.; ESCMID Study Group for Antimicrobial Policies (ESGAP); ISC Group on Antimicrobial Stewardship. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015;70(4):1245–55.
  12. James RS, McIntosh KA, Luu SB, Cotta MO, Marshall C, Thursky KA, et al. Antimicrobial stewardship in Victorian hospitals: a statewide survey to identify current gaps. Med J Aust. 2013;199(10):692–5. doi:.
  13. Duguid M, Cruickshank M. Antimicrobial stewardship in Australian hospitals 2011. Available from:
  14. CDC. Core elements of hospital antibiotic stewardship programs 2014. Available from:
  15. The Joint Commission. Proposed Standard for Antimicrobial Stewardship in AHC, CAH, HAP, NCC, and OBS. 2015. Available from: